Sign In
Buy CERS
$2.66
-0.0400 (-1.48%)
At Close: Jun 03, 2026
Stifel Maintains Buy on Cerus, Raises Price Target to $8
12:07pm, Wednesday, 27'th May 2020Cerus Corporation Announces FDA PMA Supplement Submission For Pathogen-Reduced Cryoprecipitated Fibrinogen Complex
12:42pm, Tuesday, 26'th May 2020Cerus Corporation Announces FDA PMA Supplement Submission for Pathogen-Reduced Cryoprecipitated Fibrinogen Complex
12:30pm, Tuesday, 26'th May 2020
Cerus Corporation (Nasdaq:CERS) announced today that the Company has submitted a pre-market approval supplement (PMA-S) to the FDA for a pathogen reduced cryoprecipitated fibrinogen complex with 5-day
New Coronavirus Vaccine To Send Virus' Spike Protein To Activate Body's Immune Response
12:00pm, Tuesday, 26'th May 2020
Novavax is now beginning its clinical trials.
Cerus Corporation Announces FDA PMA Supplement Submission for Pathogen-Reduced Cryoprecipitated Fibrinogen Complex
12:00am, Tuesday, 26'th May 2020
Cerus Corporation (Nasdaq:CERS) announced today that the Company has submitted a pre-market approval supplement (PMA-S) to the FDA for a pathogen redu
The
Cerus: Surging During The COVID-19 Pandemic
12:27am, Tuesday, 12'th May 2020
Cerus Corp. is still one of my favorite COVID-19 tickers due to the need for pathogen-free blood components and growing demand for COVID-19 convalescent plasma.
Cerus Corporation (NASDAQ:CERS) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
04:15pm, Thursday, 07'th May 2020
It's been a mediocre week for Cerus Corporation (NASDAQ:CERS) shareholders, with the stock dropping 14% to US$5.31 in...
Cerus Corporation (CERS) Q1 2020 Earnings Call Transcript
11:33am, Wednesday, 06'th May 2020
Ladies and gentlemen, thank you for standing by and welcome to the Cerus Corporation Q1 2020 Earnings Conference Call. It is now my pleasure to turn the call over to your host Mr. Tim Lee. With me o
Edited Transcript of CERS earnings conference call or presentation 5-May-20 8:30pm GMT
06:28am, Wednesday, 06'th May 2020
Q2 2020 Cerus Corp Earnings Call
Cerus (CERS) Reports Q1 Loss, Tops Revenue Estimates
10:45pm, Tuesday, 05'th May 2020
Cerus (CERS) delivered earnings and revenue surprises of 0.00% and 5.74%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Cerus Q1 EPS $(0.100), Inline, Sales $24.600M Beat $23.120M Estimate
08:04pm, Tuesday, 05'th May 2020Cerus Corporation Announces First Quarter 2020 Results
08:01pm, Tuesday, 05'th May 2020
Cerus Corporation (Nasdaq: CERS) today announced financial results for the first quarter ended March 31, 2020.
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks hitting 52-week highs May 5.)
Arcturus Therapeutics Ltd (...
